BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Pharm Country

  West Pharmaceutical Services Makes Investment In NanoPass

  April 25, 2016

   · 

  3 min read
• MEDTECH’s ROSA Robotic Surgery System To Be Featured At The 84th American Association Of Neurological Surgeons (AANS) Annual Meeting

  April 25, 2016

   · 

  3 min read
• Aralez To Present At The Bloom Burton & Co. Healthcare Investor Conference

  April 25, 2016

   · 

  1 min read
• Drug Development

  PHARNEXT Announces The Opening Of The First U.S. Study Site For Its PLEO-CMT International Pivotal Phase 3 Trial In Charcot-Marie-Tooth Disease Type 1A

  April 25, 2016

   · 

  5 min read
• Business

  Biostage Appoints Ginger Abraham-Freel As Director Of Quality And Operations To Advance Its Bioengineered Organ Implants

  April 25, 2016

   · 

  5 min read
• Drug Development

  AbGenomics International Announces Promising Final Results From Their Phase II Open-Label Clinical Study Of Abgn-168H/Neihulizumab In Psoriatic Arthritis, A T-Cell Mediated Disease

  April 25, 2016

   · 

  3 min read
• Drug Development

  BioPharmX Announces Full Patient Enrollment In Phase 2a Study Of BPX-01 Topical Antibiotic For Acne

  April 25, 2016

   · 

  3 min read
• Business

  Helsinn Group Signs Exclusive Agreement With Purdue Pharma Canada For The Distribution And Licensing Rights Of Akynzeo (Netupitant/Palonosetron Combo) In Canada

  April 25, 2016

   · 

  4 min read
• Business

  American Skin Association Announces New Board Of Directors Members Gitte Aabo Of LEO Pharma And Dr. George Cotsarelis Of Penn Medicine

  April 25, 2016

   · 

  2 min read
• Deals

  Aytu BioScience Enters $2 Billion Testosterone Replacement Market With Acquisition Of U.S. Commercial Rights To Natesto

  April 25, 2016

   · 

  11 min read